Expansion of β-cell mass in response to pregnancy
Open accessAbstract
Inadequate β-cell mass can lead to insulin insufficiency and diabetes. During times of prolonged metabolic demand for insulin, the endocrine pancreas can respond by increasing β-cell mass, both by increasing cell size and by changing the balance between β-cell proliferation and apoptosis. In this paper, we review recent advances in our understanding of the mechanisms that control the adaptive expansion of β-cell mass, focusing on the islet’s response to pregnancy, a physiological state of insulin resistance. Functional characterization of factors controlling both β-cell proliferation and survival might not only lead to the development of successful therapeutic strategies to enhance the response of the β-cell to increased metabolic loads, but also improve islet transplantation regimens.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 109 cited sources checked · 0 supported · 0 flagged
- Findingcitation
Gene expression analysis during the peak of β-cell DNA synthesis identified many genes not previously reported to play a role in β-cell expansion.
“Gene expression analysis during the peak of β-cell DNA synthesis not only showed induction of Prlr and Cdk4 expression in the islets of pregnant mice, but also identified many genes that had not previously been reported to play a role in β-cell expansion, which we discuss further below [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- Rests on an assumption: Gene expression changes in islets during the peak of DNA synthesis reflect the mechanisms that drive β-cell expansion during pregnancy.
- Findingcitation
Both Cish and Socs2 are robustly induced at the transcriptional level in pancreatic islets during pregnancy.
“Both Cish and Socs2, members of the suppressor of cytokine signaling family of proteins, are robustly induced at the transcriptional level in pancreatic islets during pregnancy [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- Rests on an assumption: Gene expression changes in islets during the peak of DNA synthesis reflect the mechanisms that drive β-cell expansion during pregnancy.
- Findingcitation
Birc5 gene expression in islets closely mirrors the proliferative profile reflected by Ki67 mRNA levels throughout pregnancy, obesity and β-cell recovery after injury.
“Indeed, Birc5 gene expression in islets closely mirrors the proliferative profile as reflected in mRNA levels of Ki67 throughout pregnancy, obesity and β-cell recovery after injury [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- Rests on an assumption: Gene expression changes in islets during the peak of DNA synthesis reflect the mechanisms that drive β-cell expansion during pregnancy.
- Findingcitation
During the peak of β-cell proliferation in pregnancy, the antiapoptotic gene Birc5 is upregulated.
“In this context, it is interesting that during the peak of β-cell proliferation in pregnancy, the antiapoptotic gene Birc5 was upregulated [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- Rests on an assumption: Gene expression changes in islets during the peak of DNA synthesis reflect the mechanisms that drive β-cell expansion during pregnancy.
- Findingcitation
In islets of pregnant mice at the peak of β-cell DNA synthesis, Prlr and Cdk4 expression are induced.
“Gene expression analysis during the peak of β-cell DNA synthesis not only showed induction of Prlr and Cdk4 expression in the islets of pregnant mice, but also identified many genes that had not previously been reported to play a role in β-cell expansion, which we discuss further below [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- Rests on an assumption: Gene expression changes in islets during the peak of DNA synthesis reflect the mechanisms that drive β-cell expansion during pregnancy.
- Premisecitation
The ability of β-cells to expand after injury or a high-fat diet declines with age in both humans and mice.
“The capacity of the β-cell to expand in response to injury or a high-fat diet decreases with age in both humans and mice [28,29].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [28] Tschen, 2009, Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice, Diabetes source
Not checked in the free run.
- cites [29] Rankin, 2009, Adaptive beta-cell proliferation is severely restricted with advanced age, Diabetes source
Not checked in the free run.
- Premisecitation
β-cell replication and hypertrophy occur during periods of intense metabolic demand in young mice and humans.
“There is now growing evidence suggesting that β-cell replication and hypertrophy, in both young mice and humans, occurs during periods of intense metabolic demand [6,9–11], e.g. in hyperglycemia after β-cell ablation [12,13] and in the neonatal period [14–18] (Figure 1b).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [6] Butler, 2003, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes source
Not checked in the free run.
- cites [9] Parsons, 1992, Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion, Endocrinology source
Not checked in the free run.
- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- cites [11] Pick, 1998, Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat, Diabetes source
Not checked in the free run.
- Premisecitation
Inducing cell cycle arrest specifically in β-cells by p27 overexpression or postnatal Cdk4 deletion causes β-cell mass to decrease or fail to expand.
“For instance, when cell cycle arrest is induced specifically in β-cells by overexpression of p27 [24] or by deletion of Cdk4 postnatally, β-cell mass decreases or fails to expand, which would not be the case if neogenesis or transdifferentiation were major sources of new β-cells [25,26].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [24] Uchida, 2005, Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice, Nat. Med. source
Not checked in the free run.
- cites [25] Rane, 1999, Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia, Nat. Genet. source
Not checked in the free run.
- cites [26] Martin, 2003, Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number, Oncogene source
Not checked in the free run.
- Premisenone given
When metabolic demand for insulin is prolonged, the endocrine pancreas can raise β-cell mass by enlarging cells and by altering the balance between β-cell proliferation and apoptosis.
“During times of prolonged metabolic demand for insulin, the endocrine pancreas can respond by increasing β-cell mass, both by increasing cell size and by changing the balance between β-cell proliferation and apoptosis.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Matveyenko, 2008, Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- cites [2] Sorenson, 1997, Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones, Horm. Metab. Res. source
Not checked in the free run.
- cites [3] Kloppel, 1985, Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited, Surv. Synth. Pathol. Res.
Not checked in the free run.
- Premisecitation
Adult β-cells can dynamically expand their functional mass in response to systemic increases in insulin demand, at least in rodents and possibly in humans.
“Once thought to be static and slow in turnover, it is now known that adult β-cells can dynamically respond to systemic increases in insulin demand (here defined as an increase in metabolic load) by dramatically expanding their functional mass, at least in rodents and possibly in humans, as seen during aging [1], pregnancy [2], obesity [3] and genetic insulin resistance [4].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Matveyenko, 2008, Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats, Am. J. Physiol. Endocrinol. Metab. source
Not checked in the free run.
- cites [2] Sorenson, 1997, Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones, Horm. Metab. Res. source
Not checked in the free run.
- cites [3] Kloppel, 1985, Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited, Surv. Synth. Pathol. Res.
Not checked in the free run.
- Interpretationreasoning
Under most physiological conditions, expansion of existing β-cell mass through hypertrophy and cell division is a major driver of postnatal islet expansion.
“Regardless of whether and to what extent neogenesis or trans-differentiation might be exploitable to increase β-cell mass, it is clear that under most physiological circumstances the expansion of existing β-cell mass by hypertrophy and cell division is a major driver of postnatal islet expansion.”
Quote in the paperNot a substantial claim - Premisecitation
In obese patients, blood glucose levels are inversely associated with β-cell volume below a certain threshold.
“Furthermore, studies of obese patients (including non-diabetic, prediabetic and diabetic groups) reported an inverse relationship between blood glucose levels and β-cell volume below a certain threshold [8], illustrating the importance of β-cell mass as a central factor determining insulin secretory capacity.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Ritzel, 2006, Relationship between beta-cell mass and fasting blood glucose concentration in humans, Diabetes Care source
Not checked in the free run.
- Premisecitation
Insufficient β-cell mass can cause insulin insufficiency and diabetes.
“Inadequate β-cell mass can lead to insulin insufficiency and diabetes.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Butler, 2003, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes source
Not checked in the free run.
- cites [7] Meier, 2005, Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?, Diabetologia source
Not checked in the free run.
- Premisecitation
Genome-wide association studies link CDKN2A, CDKN2B, CDC123 and CDKAL1 to type 2 diabetes risk.
“Strikingly, recent genome-wide association studies link the cyclin-dependent kinase inhibitors CDKN2A and CDKN2B (encoding p15Ink4b) and the cell cycle regulators CDC123 and CDKAL1 to the risk of type 2 diabetes [34–37].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [34] Zeggini, 2007, Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes, Science source
Not checked in the free run.
- cites [35] Scott, 2007, A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, Science source
Not checked in the free run.
- cites [36] Saxena, 2007, Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, Science source
Not checked in the free run.
- cites [37] Zeggini, 2008, Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes, Nat. Genet. source
Not checked in the free run.
- Interpretationreasoning
In utero exposure to impaired glucose homeostasis alters the epigenetic memory of β-cells.
“Interestingly, the maternal genotype had a significant effect on the phenotype of female offspring that became pregnant, as assessed by serum glucose levels [46], suggesting that in utero exposure to impaired glucose homeostasis alters the epigenetic memory of β-cells [47–49].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [47] Aerts, 1997, The endocrine pancreas in virgin and pregnant offspring of diabetic pregnant rats, Diabetes Res. Clin. Pract. source
Not checked in the free run.
- cites [48] Boloker, 2002, Gestational diabetes leads to the development of diabetes in adulthood in the rat, Diabetes source
Not checked in the free run.
- cites [49] Aerts, 1998, Ultrastructural evaluation of B–cell recruitment in virgin and pregnant offspring of diabetic mothers, Diabetes Res. Clin. Pract. source
Not checked in the free run.
- Premisecitation
The maternal genotype significantly affects the phenotype of female offspring that become pregnant, as assessed by serum glucose levels.
“Interestingly, the maternal genotype had a significant effect on the phenotype of female offspring that became pregnant, as assessed by serum glucose levels [46], suggesting that in utero exposure to impaired glucose homeostasis alters the epigenetic memory of β-cells [47–49].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [46] Huang, 2009, Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy, Endocrinology source
Not checked in the free run.
- Premisecitation
When compensatory β-cell mass expansion fails during gestation, diabetes results.
“However, as with obese individuals, when compensatory β-cell mass expansion fails during gestation, diabetes results.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Kim, 2002, Gestational diabetes and the incidence of type 2 diabetes: a systematic review, Diabetes Care source
Not checked in the free run.
- Interpretationcitation
The capacity of β-cells to adapt successfully to increased metabolic load is a shared requirement for preventing both gestational diabetes and type 2 diabetes.
“Interestingly, long-term follow-up studies show that 70% of women who are diabetic during pregnancy develop type 2 diabetes later in life, emphasizing that the ability of β-cells to successfully adapt to increases in metabolic load is a common theme for preventing both gestational diabetes and type 2 diabetes [42].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] Kim, 2002, Gestational diabetes and the incidence of type 2 diabetes: a systematic review, Diabetes Care source
Not checked in the free run.
- Premisecitation
β-cell proliferation increases dramatically during pregnancy in rodents.
“Studies in rodents found a 3–4-fold increase in β-cell mass during gestation and demonstrated that in addition to substantial maternal β-cell hypertrophy [2,10,43], β-cell proliferation also increases dramatically during pregnancy [9,10] (Figure 2b,c).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Parsons, 1992, Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion, Endocrinology source
Not checked in the free run.
- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- Premisecitation
The age-related decline in β-cell expansion correlates with epigenetic changes at the Cdkn2a locus, which encodes p16Ink4a and p19Arf.
“This decline correlates with epigenetic changes at the Cdkn2a locus, which encodes the cell cycle inhibitors, p16Ink4a and p19Arf [30,31].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [30] Dhawan, 2009, Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation, Genes Dev. source
Not checked in the free run.
- cites [31] Chen, 2009, Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus, Genes Dev. source
Not checked in the free run.
- Premisecitation
Genetic obesity models such as ZDF rats and IAPP transgenic mice reproduce the decrease in β-cell mass caused by increased apoptosis that accompanies type 2 diabetes onset in humans.
“Genetic models of obesity such as the Zucker diabetic fatty (ZDF) rat ( fa/fa) and transgenic mice overexpressing human islet amyloid polypeptide (IAPP) recapitulate the decrease in β-cell mass caused by increased β-cell apoptosis that accompanies the onset of type 2 diabetes in humans [11,38].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [11] Pick, 1998, Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat, Diabetes source
Not checked in the free run.
- cites [38] Butler, 2003, Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid, Diabetes source
Not checked in the free run.
- Interpretationcitation
Lactogenic activity is vital for β-cells to increase proliferation and function in response to pregnancy.
“Notably, this peak in DNA synthesis coincides with increased lactogen levels, suggesting that lactogenic activity is vital for the ability of β-cells to enhance proliferation and function in response to pregnancy [9].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Parsons, 1992, Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion, Endocrinology source
Not checked in the free run.
- Premisecitation
Seventy percent of women who are diabetic during pregnancy develop type 2 diabetes later in life.
“Interestingly, long-term follow-up studies show that 70% of women who are diabetic during pregnancy develop type 2 diabetes later in life, emphasizing that the ability of β-cells to successfully adapt to increases in metabolic load is a common theme for preventing both gestational diabetes and type 2 diabetes [42].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Kim, 2002, Gestational diabetes and the incidence of type 2 diabetes: a systematic review, Diabetes Care source
Not checked in the free run.
- Premisecitation
In rodents, β-cell mass increases 3-4-fold during gestation.
“Studies in rodents found a 3–4-fold increase in β-cell mass during gestation and demonstrated that in addition to substantial maternal β-cell hypertrophy [2,10,43], β-cell proliferation also increases dramatically during pregnancy [9,10] (Figure 2b,c).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [2] Sorenson, 1997, Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones, Horm. Metab. Res. source
Not checked in the free run.
- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- cites [43] Parsons, 1995, Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones, Endocrinology source
Not checked in the free run.
- Premisecitation
β-cell mass returns to normal within ten days after birth through increased β-cell apoptosis, decreased proliferation and reduced β-cell size.
“Intriguingly, β-cell mass returns to normal levels within ten days after birth through increased β-cell apoptosis, decreased proliferation and reduced β-cell size [41] (Figure 2d).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Scaglia, 1995, Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas, Endocrinology source
Not checked in the free run.
- Premisecitation
The non-diabetic Zucker fatty rat increases its β-cell mass through proliferation, hypertrophy and neogenesis without evidence of increased apoptosis.
“By contrast, the non-diabetic Zucker fatty (ZF) rat, which also becomes obese and resistant to insulin, adequately increases its β-cell mass through increased β-cell proliferation, hypertrophy and neogenesis without evidence of increased apoptosis [11].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Pick, 1998, Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat, Diabetes source
Not checked in the free run.
- Premisecitation
Maternal β-cell hypertrophy is substantial during pregnancy in rodents.
“Studies in rodents found a 3–4-fold increase in β-cell mass during gestation and demonstrated that in addition to substantial maternal β-cell hypertrophy [2,10,43], β-cell proliferation also increases dramatically during pregnancy [9,10] (Figure 2b,c).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [2] Sorenson, 1997, Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones, Horm. Metab. Res. source
Not checked in the free run.
- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- cites [43] Parsons, 1995, Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones, Endocrinology source
Not checked in the free run.
- Premisecitation
The peak in DNA synthesis coincides with increased lactogen levels.
“Notably, this peak in DNA synthesis coincides with increased lactogen levels, suggesting that lactogenic activity is vital for the ability of β-cells to enhance proliferation and function in response to pregnancy [9].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Parsons, 1992, Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion, Endocrinology source
Not checked in the free run.
- Premisecitation
Increased β-cell mass is an adaptation to the progressive insulin resistance that develops during pregnancy in women.
“It has been recognized for decades that increased β-cell mass is an adaptation to the progressive insulin resistance that develops during pregnancy in women.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [2] Sorenson, 1997, Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones, Horm. Metab. Res. source
Not checked in the free run.
- cites [39] Alsat, 1997, Human placental growth hormone, Am J. Obstet. Gynecol. source
Not checked in the free run.
- Premisecitation
Changing p16Ink4a expression in transgenic mice markedly alters the proliferative capacity of β-cells.
“In fact, manipulation of p16Ink4a expression in transgenic mice dramatically alters the proliferative capacity of β-cells, precisely as would be expected if p16Ink4a limits proliferation in aging β-cells [32].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Krishnamurthy, 2006, p16INK4a induces an age-dependent decline in islet regenerative potential, Nature source
Not checked in the free run.
- Premisecitation
In skeletal muscle, Ngf expression correlates strongly with the islet cell cycle regulatory module that is activated during obesity.
“Ngf expression in skeletal muscle is strongly correlated with the islet cell cycle regulatory module activated during obesity, again suggesting a link to β-cell proliferation [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Keller, 2008, A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility, Genome Res. source
Not checked in the free run.
- Interpretationcitation
The ability of β-cells to compensate during metabolic stress requires simultaneous induction of both proliferative and survival pathways.
“Simultaneous ablation of Caspase 3 in these transgenic mice protects the β-cell from c-Myc-induced apoptosis and diabetes, supporting the notion that the ability of β-cells to compensate during metabolic stress requires the simultaneous induction of both the proliferative and survival pathways [62].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Radziszewska, 2009, Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation, J. Biol. Chem. source
Not checked in the free run.
- Interpretationcitation
To expand β-cell mass successfully under increased metabolic load, the proliferating β-cell must induce mechanisms that ensure its survival through mitosis.
“To successfully expand β-cell mass in response to increased metabolic load, the proliferating β-cell needs to induce mechanisms ensuring its survival through mitosis.”
Quote in the paperSubstantial claim - Premisecitation
Cish and Socs2 act as negative regulators of tyrosine kinases and receptors that affect β-cell proliferation, including the prolactin receptor.
“Each acts as a negative regulator of a variety of tyrosine kinases and receptors affecting β-cell proliferation, including the prolactin receptor [46].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Huang, 2009, Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy, Endocrinology source
Not checked in the free run.
- Interpretationcitation
Birc5 is a crucial and universal component that ensures successful expansion of β-cell mass in various conditions.
“These studies implicate Birc5 as a crucial and universal component that ensures successful expansion of β-cell mass in various conditions [60] (Figure 4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [60] Dohi, 2006, Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice, EMBO Rep. source
Not checked in the free run.
- Premisecitation
The onset of type 2 diabetes in humans and rodents is accompanied by a progressive decrease in β-cell mass resulting from increased β-cell apoptosis.
“The onset of type 2 diabetes in both humans and rodents is accompanied by a progressive decrease in β-cell mass resulting from an increase in β-cell apoptosis.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3] Kloppel, 1985, Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited, Surv. Synth. Pathol. Res.
Not checked in the free run.
- cites [6] Butler, 2003, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes source
Not checked in the free run.
- Premisecitation
STAT5-dependent downregulation of menin (Men1) and subsequent inhibition of p18 and p27 are crucial events in β-cell expansion during pregnancy.
“In addition, STAT5-dependent downregulation of the tumor suppressor gene menin (Men1) and subsequent inhibition of p18 and p27 are crucial events in β-cell expansion during pregnancy [56].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56] Karnik, 2007, Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus, Science source
Not checked in the free run.
- Interpretationcitation
The metabolic state of the fetus determines the epigenetic fate of the β-cell.
“Again, it is clear that the metabolic state of the fetus determines the epigenetic fate of the β-cell.”
Quote in the paperSubstantial claim - Premisecitation
Simultaneous ablation of Caspase 3 in c-Myc transgenic mice protects β-cells from c-Myc-induced apoptosis and diabetes.
“Simultaneous ablation of Caspase 3 in these transgenic mice protects the β-cell from c-Myc-induced apoptosis and diabetes, supporting the notion that the ability of β-cells to compensate during metabolic stress requires the simultaneous induction of both the proliferative and survival pathways [62].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Radziszewska, 2009, Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation, J. Biol. Chem. source
Not checked in the free run.
- Premisecitation
The proliferative response of β-cells to pregnancy in mice is dependent on Foxm1 itself.
“Other known Foxm1 targets such as Skp2 have already been implicated in β-cell compensation in response to diet-induced obesity [65], and the proliferative response of the β-cell to pregnancy in mice is dependent on Foxm1 itself [66].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Zhang, 2009, Gestational diabetes resulting from impaired {beta}-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen, Diabetes
Not checked in the free run.
- Premisecitation
Inhibition of an inhibitor has been used recently to enhance β-cell proliferation by attenuating signals that restrain GLP-1 action.
“An analogous strategy, i.e. the inhibition of an inhibitor, has been used recently as a solution to enhance β-cell proliferation by attenuating signals that restrain GLP-1 action [72].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [72] Klinger, 2008, Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14, Diabetes source
Not checked in the free run.
- Premisecitation
In a rodent model of intrauterine growth retardation, epigenetic marks at the Pdx1 promoter are altered in offspring of dams whose uterine arteries were ligated.
“In this model, epigenetic marks at the promoter of the β-cell transcription factor Pdx1 were found to be altered in the offspring of dams in which the uterine arteries had been ligated, causing intrauterine growth retardation [51].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Park, 2008, Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1, J. Clin. Invest.
Not checked in the free run.
- Premisecitation
In pancreatic tissue sections from type 2 diabetics, apoptotic β-cells are often organized in pairs.
“In pancreatic tissue sections from type 2 diabetics, apoptotic β-cells are often organized in pairs, a finding that has been interpreted as β-cell apoptosis following mitosis as a mechanism of β-cell death [57].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Ritzel, 2003, Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis, Diabetes source
Not checked in the free run.
- Premisecitation
Tph1 and Tph2 were among the genes with the largest fold change in steady-state mRNA levels in islets during pregnancy.
“Two of the genes with the most dramatic fold change in steady state mRNA levels in islets during pregnancy were tryptophan hydroxylase 1 and 2 (Tph1 and Tph2) [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- Premisecitation
Treating donor islets with Ngf before transplantation improves the outcome of islet transplantation.
“the outcome of islet transplantation is improved by pre-treating donor islets with Ngf [74].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] Miao, 2006, In vitro and in vivo improvement of islet survival following treatment with nerve growth factor, Transplantation source
Not checked in the free run.
- Premisecitation
Foxm1 directly activates transcription of Birc5.
“Of the transcriptional mediators, Foxm1 has been shown to directly activate the transcription of Birc5, the antiapoptotic gene induced during pregnancy discussed previously in this review [63].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Wang, 2005, Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase, Mol. Cell Biol. source
Not checked in the free run.
- Premisecitation
HNF-4α is required in β-cells for the proliferative response of pregnancy through activation of the Ras/ERK signaling cascade, at least in part through regulation of ST5.
“Additionally, a recent study showed that the orphan nuclear receptor hepatocyte nuclear factor-4 (HNF-4)α is required in β-cells for the proliferative response of pregnancy through activation of the Ras/ERK signaling cascade, at least in part through the regulation of the guanine nucleotide exchange factor ST5 (Figure 3) [55].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Gupta, 2007, Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha, Genes Dev. source
Not checked in the free run.
- Premisecitation
Other known Foxm1 targets such as Skp2 have been implicated in β-cell compensation in response to diet-induced obesity.
“Other known Foxm1 targets such as Skp2 have already been implicated in β-cell compensation in response to diet-induced obesity [65], and the proliferative response of the β-cell to pregnancy in mice is dependent on Foxm1 itself [66].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Zhong, 2007, Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells, J. Clin. Invest. source
Not checked in the free run.
- Premisecitation
Cish and Socs2 decrease activation of STAT5.
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [67] Endo, 2003, CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation, J. Biochem. source
Not checked in the free run.
- cites [68] Greenhalgh, 2002, Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b), Mol. Endocrinol. source
Not checked in the free run.
- Interpretationcitation
Diabetes onset results from a failure of β-cell expansion, rather than only from a decrease in existing β-cell mass.
“Studies in rodents [38,58] and primary human islets [57] also suggest that diabetes onset is a result of a failure of β-cell expansion, rather than a decrease in existing β-cell mass only (Figure 4).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [38] Butler, 2003, Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid, Diabetes source
Not checked in the free run.
- cites [58] Donath, 1999, Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes, Diabetes source
Not checked in the free run.
- cites [57] Ritzel, 2003, Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis, Diabetes source
Not checked in the free run.
- Premisecitation
Mice lacking Tph1 have impaired insulin secretion.
“Paulmann and colleagues found impaired insulin secretion in mice deficient for Tph1 [79].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Paulmann, 2009, Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation, PLoS Biol. source
Not checked in the free run.
- Interpretationcitation
Comparison of different β-cell expansion paradigms suggests that the islet can use various mechanisms to increase its mass according to the metabolic setting.
“Comparison of several paradigms of β-cell expansion suggests that diverse mechanisms can be used by the islet to expand its mass depending on the metabolic setting [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
- Interpretationreasoning
If the balance between β-cell growth and loss is improperly shifted away from the usual growth and survival response during expansion, β-cell compensation can fail, leading to gestational diabetes.
“if this equilibrium is skewed improperly away from normal induction of β-cell growth and survival during β-cell expansion, β-cell compensation can fail, resulting in gestational diabetes (Figure 4).”
Quote in the paperSubstantial claim- Rests on an assumption: β-cell mass is normally maintained by a tight equilibrium between growth and loss, and it compensates for higher insulin demand such as in pregnancy.
- May combine two claims. 21
- Classified as probably not a substantial claim. 4
May combine two claims.
PremisecitationPeople with type 1 or type 2 diabetes have reduced β-cell mass and increased β-cell apoptosis, with loss exceeding growth.
“Indeed, individuals with either type 1 or type 2 diabetes show decreases in β-cell mass and increases in β-cell apoptosis, outweighing that of β-cell growth [6,7].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [6] Butler, 2003, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes source
Not checked in the free run.
- cites [7] Meier, 2005, Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?, Diabetologia source
Not checked in the free run.
May combine two claims.
PremisecitationIn young adult mice, most new β-cells come from replication of pre-existing β-cells, and few if any come from progenitors under normal conditions.
“Genetic lineage tracing studies performed in the young adult mouse indicate that the great majority of new β-cells are derived through replication of pre-existing β-cells and few, if any, newly formed β-cells stem from progenitor populations under normal circumstances, at least in rodents [23].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Dor, 2004, Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationThe peak of BrdU incorporation occurs about two-thirds of the way through gestation, and labeling returns to pre-pregnancy levels shortly before parturition.
“The peak of bromodeoxyuridine (BrdU) incorporation, an indicator of DNA synthesis during S-phase, occurs about two-thirds of the way through the gestational period, with labeling returning to pre-pregnancy levels shortly before parturition.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Parsons, 1992, Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion, Endocrinology source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese genetic data indicate that β-cell proliferation matters at some point during ontogeny, but they do not show when in life it is important.
“These genetic data together indicate a role for β-cell proliferation at some time during ontogeny; they do not, however, address the question of when in life β-cell proliferation is important.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMaternal IGF-1 levels rise in response to increased growth hormone levels.
“Placental lactogen and growth hormone increase hepatic gluconeogenesis and lipolysis, and maternal IGF-1 levels increase in response to increased growth hormone levels [2,39].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Sorenson, 1997, Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones, Horm. Metab. Res. source
Not checked in the free run.
- cites [39] Alsat, 1997, Human placental growth hormone, Am J. Obstet. Gynecol. source
Not checked in the free run.
May combine two claims.
PremisecitationPancreata from people with long-standing type 1 diabetes show measurable β-cell mass and evidence of β-cell apoptosis.
“Intriguingly, pancreata from individuals with long-standing type 1 diabetes displayed not only measurable β-cell mass, but also evidence of β-cell apoptosis [7].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Meier, 2005, Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?, Diabetologia source
Not checked in the free run.
May combine two claims.
PremisecitationPlacental lactogen and growth hormone increase hepatic gluconeogenesis and lipolysis.
“Placental lactogen and growth hormone increase hepatic gluconeogenesis and lipolysis, and maternal IGF-1 levels increase in response to increased growth hormone levels [2,39].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Sorenson, 1997, Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones, Horm. Metab. Res. source
Not checked in the free run.
- cites [39] Alsat, 1997, Human placental growth hormone, Am J. Obstet. Gynecol. source
Not checked in the free run.
May combine two claims.
PremisecitationA cell cycle regulatory module in islets distinguishes diabetes-resistant from diabetes-susceptible leptin-deficient Ob/Ob mouse strains and predicts their predisposition to diabetes.
“Furthermore, gene expression studies uncovered a cell cycle regulatory module in islets that distinguishes between diabetes-resistant and diabetes-susceptible strains of leptin-deficient Ob/Ob mice, and successfully predicts their predisposition to diabetes [33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Keller, 2008, A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility, Genome Res. source
Not checked in the free run.
May combine two claims.
PremisecitationPregnant mice heterozygous for the prolactin receptor null mutation show reduced β-cell proliferation, decreased β-cell size and mass, and impaired glucose tolerance.
“The requirement of the prolactin receptor for β-cell adaptation during pregnancy was demonstrated using pregnant mice heterozygous for the prolactin receptor null mutation. These mice exhibited reduced β-cell proliferation, decreased β-cell size and mass, and impaired glucose tolerance [46].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Huang, 2009, Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy, Endocrinology source
Not checked in the free run.
May combine two claims.
PremisecitationGlobal deletion of the prolactin receptor reduces β-cell mass and mildly impairs insulin secretion.
“Similarly, global deletion of the prolactin receptor (PRLR), through which both PRL and PL signal, reduces β-cell mass and mildly impairs insulin secretion [45].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Freemark, 2002, Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance, Endocrinology source
Not checked in the free run.
May combine two claims.
PremisecitationOverexpression of placental lactogen in β-cells causes a dramatic increase in β-cell proliferation and β-cell mass, even resulting in hypoglycemia.
“As a proof of principle for direct regulation of β-cell proliferation by prolactin (PRL) and placental lactogen (PL), overexpression of PL in the β-cell caused a dramatic increase in β-cell proliferation and β-cell mass, even resulting in hypoglycemia [44].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Vasavada, 2000, Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia, J. Biol. Chem. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe pregnancy paradigm is a unique example of rapid and reversible β-cell mass expansion, with distinct bursts of β-cell proliferation and apoptosis in a physiological setting.
“Although the mechanisms underlying these processes are not yet known, the pregnancy paradigm is a unique example of rapid and reversible β-cell mass expansion, with distinct bursts of both β-cell proliferation and β-cell apoptosis occurring in a physiological setting.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA subset of obese individuals cannot compensate for insulin resistance and develops type 2 diabetes, partly because of increased β-cell apoptosis.
“A subset of obese individuals is unable to compensate for insulin resistance, and thus develop type 2 diabetes mellitus, due in part to increased β-cell apoptosis [3,6].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [3] Kloppel, 1985, Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited, Surv. Synth. Pathol. Res.
Not checked in the free run.
- cites [6] Butler, 2003, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationNgfr expression is markedly increased in pancreatic islets during pregnancy and after β-cell ablation.
“expression of signaling molecules such as the nerve growth factor receptor, Ngfr, is also dramatically upregulated in islets during pregnancy and during recovery after β-cell ablation [10].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Rieck, 2009, The transcriptional response of the islet to pregnancy in mice, Mol. Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationHepatocyte growth factor boosts β-cell proliferation and mass, and enhances islet transplant outcomes in vivo.
“hepatocyte growth factor, Hgf, increases β-cell proliferation and mass, and improves islet transplant outcomes in vivo [75,76].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [75] Garcia-Ocana, 2000, Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia, J. Biol. Chem. source
Not checked in the free run.
- cites [76] Fiaschi-Taesch, 2008, Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets, Diabetes source
Not checked in the free run.
May combine two claims.
PremisecitationBirc5 has a bifunctional role, controlling both proliferation and inhibition of apoptosis specifically in the β-cell in vivo.
“A recent study showed a bifunctional role for Birc5 (survivin), controlling both proliferation and inhibition of apoptosis specifically in the β-cell in vivo [59].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Jiang, 2008, Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin, Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSerotonin is synthesized within β-cells and stored with insulin in secretory granules.
“it has been known for a long time that serotonin (5-hydroxytryptamine; 5-HT) is synthesized within β-cells and stored together with insulin in secretory granules [77,78]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [77] Ekholm, 1971, Monoamines in the pancreatic islets of the mouse. Subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography, Diabetologia source
Not checked in the free run.
- cites [78] Richmond, 1996, Calcium- and barium-dependent exocytosis from the rat insulinoma cell line RINm5F assayed using membrane capacitance measurements and serotonin release, Pflugers Arch. source
Not checked in the free run.
May combine two claims.
PremisecitationFoxm1 is required for maintenance of β-cell mass postnatally and during β-cell recovery after partial pancreatectomy.
“Indeed, Foxm1 is required for the maintenance of β-cell mass postnatally and during β-cell recovery after partial pancreatectomy [64].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [64] Ackermann Misfeldt, 2008, Beta-cell proliferation, but not neogenesis, following 60% partial pancreatectomy is impaired in the absence of FoxM1, Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe intrauterine milieu affects glucose homeostasis in the adult.
“These findings provide a link to the well-known phenomenon that the intrauterine milieu affects glucose homeostasis in the adult (reviewed in [50]).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Pinney, 2009, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab.
Not checked in the free run.
May combine two claims.
PremisecitationSTAT5 has pro-proliferative targets such as Cyclin D2, anti-apoptotic targets such as Bcl-xl and Bcl6, and targets involved in β-cell function.
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [69] Friedrichsen, 2003, Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells, Mol. Endocrinol. source
Not checked in the free run.
- cites [56] Karnik, 2007, Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus, Science source
Not checked in the free run.
- cites [70] Fujinaka, 2007, Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation, J. Biol. Chem. source
Not checked in the free run.
May combine two claims.
PremisecitationBirc5-deficient animals progressively lose β-cell mass after 2 weeks of age, and Birc5-deficient cells exhibit dysmorphic nuclei consistent with defective cell division.
“Birc5-deficient animals progressively lose β-cell mass after 2 weeks of age, and Birc5-deficient cells exhibit dysmorphic nuclei, consistent with defective cell division [59].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [59] Jiang, 2008, Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin, Diabetes source
Not checked in the free run.
May combine two claims.
Premisecitationβ-cell-specific overexpression of c-Myc in transgenic mice increases β-cell proliferation and also increases apoptosis, leading to diabetes.
“On the other hand, β-cell specific overexpression of c-Myc in transgenic mice not only increases β-cell proliferation, but also increases apoptosis, leading to the development of diabetes [61].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] Laybutt, 2002, Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes, Diabetes source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationActivation of STAT5, MAPK, phosphatidylinositol 3-kinase and IRS1/2 enhances β-cell compensation downstream of the prolactin receptor in vitro.
“Although activation of multiple signaling pathways such as STAT5, MAPK and phosphatidylinositol 3-kinase and IRS1/2 enhances β-cell compensation downstream of the prolactin receptor in vitro [52–54], it is not clear whether PRL and/or PL stimulate these pathways in vivo.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [52] Brelje, 2004, Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans, Endocrinology source
Not checked in the free run.
- cites [53] Amaral, 2004, Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy, J. Endocrinol. source
Not checked in the free run.
- cites [54] Amaral, 2003, Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway, Horm. Metab. Res. source
Not checked in the free run.
May combine two claims.
Premisecitation5-HT is coupled by transglutaminases to two small GTPases, making them constitutively active and promoting insulin secretion.
“5-HT is coupled via the action of transglutaminases to two small GTPases, rendering the latter constitutively active and promoting insulin secretion.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Paulmann, 2009, Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation, PLoS Biol. source
Not checked in the free run.
The paper relies on this without support.
Gene expression changes in islets during the peak of DNA synthesis reflect the mechanisms that drive β-cell expansion during pregnancy.
“Gene expression analysis during the peak of β-cell DNA synthesis not only showed induction of Prlr and Cdk4 expression in the islets of pregnant mice, but also identified many genes that had not previously been reported to play a role in β-cell expansion, which we discuss further below [10].”
The paper relies on this without support.
β-cell mass is maintained by the balance between cell renewal/growth and cell loss.
“In adult mammals, β-cell mass is maintained by the balance between cell renewal and growth (cell replication, hypertrophy, neogenesis) and cell loss (cell death, atrophy, autophagy) (Figure 1a).”
The paper relies on this without support.
β-cell mass is normally maintained by a tight equilibrium between growth and loss, and it compensates for higher insulin demand such as in pregnancy.
“The balance between β-cell growth and loss is tightly regulated and functional β-cell mass normally compensates for increased demands for insulin, for example, during pregnancy.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mechanisms underlying pancreatic β-cell expansion in physiological settings may differ between species.
“Although the mechanisms underlying pancreatic β-cell expansion in physiological settings may differ between species36,37, age-dependent restriction of β-cell proliferation is a conserved feature in mice and humans9,10.”
From PDGF signalling controls age-dependent proliferation in pancreatic β-cells (2011) · cites this paper as [37]
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · see citing works
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · see citing works
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843 · see citing works
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753 · see citing works
Endocrine regulation of energy metabolism by the skeleton
Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554 · see citing works
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276 · see citing works
Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation
Dor, Y., Brown, J., Martinez, O. I., & Melton, D. A. (2004) · Nature · doi:10.1038/nature02520 · Cited by 2,219 · see citing works
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194 · see citing works
Wellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864 · see citing works
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 1× · see citing works
“In fact, manipulation of p16Ink4a expression in transgenic mice dramatically alters the proliferative capacity of β-cells, precisely as would be expected if p16Ink4a limits proliferation in aging βcells [32].”
Backgroundβ Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas
Xu, X., D’Hoker, J., Stangé, G. M., Bonné, S., Leu, N. D., Xiao, X., de Casteele, M. V., Mellitzer, G., Ling, Z., Pipeleers, D., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.015 · Cited by 989 · see citing works
Ferber, S., Halkin, A., Cohen, H., Ber, I., Einav, Y., Goldberg, I., Barshack, I., Seijffers, R., Kopolovic, J., Kaiser, N., et al. (2000) · Nature Medicine · doi:10.1038/75050 · Cited by 745 · see citing works
Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700 · cited 1× · see citing works
“For instance, when cell cycle arrest is induced specifically in β-cells by overexpression of p27 [24] or by deletion of Cdk4 postnatally, β-cell mass decreases or fails to expand, which would not be the case if neogenesis or transdifferentiation were major sources of new β-cells [25,26].”
BackgroundMeier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683 · see citing works
Park, J. H., Stoffers, D. A., Nicholls, R. D., & Simmons, R. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33655 · Cited by 640 · see citing works
Wang, I.-C., Chen, Y.-J., Hughes, D., Petrovic, V., Major, M. L., Park, H. J., Tan, Y., Ackerson, T., & Costa, R. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.10875-10894.2005 · Cited by 627 · see citing works
Recovery from diabetes in mice by β cell regeneration
Nir, T., Melton, D. A., & Dor, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32959 · Cited by 595 · see citing works
Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551 · see citing works
Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles
Brüning, J. C., Winnay, J. N., Bonner‐Weir, S., Taylor, S. I., Accili, D., & Kahn, C. R. (1997) · Cell · doi:10.1016/s0092-8674(00)81896-6 · Cited by 545 · see citing works
Sorenson, R., & Brelje, T. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979040 · Cited by 531 · see citing works
Meier, J. J., Bhushan, A., Butler, A. E., Rizza, R. A., & Butler, P. C. (2005) · Diabetologia · doi:10.1007/s00125-005-1949-2 · Cited by 493 · see citing works
Parsons, J. A. (1992) · Endocrinology · doi:10.1210/en.130.3.1459 · Cited by 476 · see citing works
β cell replication is the primary mechanism for maintaining postnatal β cell mass
Georgia, S. K., & Bhushan, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22098 · Cited by 468 · see citing works
Inada, A., Nienaber, C. E., Katsuta, H., Fujitani, Y., Levine, J., Morita, R., Sharma, A., & Bonner‐Weir, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805803105 · Cited by 447 · see citing works
Apoptosis Participates in the Remodeling of the Endocrine Pancreas in the Neonatal Rat
Scaglia, L., Cahill, C. J., Finegood, D. T., & Bonner‐Weir, S. (1997) · Endocrinology · doi:10.1210/endo.138.4.5069 · Cited by 418 · see citing works
Donath, M. Y., Gross, D. J., Cerasi, E., & Kaiser, N. (1999) · Diabetes · doi:10.2337/diabetes.48.4.738 · Cited by 405 · see citing works
Paulmann, N., Grohmann, M., Voigt, J.-P., Bert, B., Vowinckel, J., Bader, M., Skelin, M., Jevšek, M., Fink, H., Rupnik, M., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000229 · Cited by 404 · see citing works
Keller, M. P., Choi, Y., Wang, P., Belt Davis, D., Rabaglia, M. E., Oler, A. T., Stapleton, D. S., Argmann, C., Schueler, K. L., Edwards, S., et al. (2008) · Genome Research · doi:10.1101/gr.074914.107 · Cited by 377 · see citing works
Chen, H., Gu, X., Su, I.-H., Bottino, R., Contreras, J. L., Tarakhovsky, A., & Kim, S. K. (2009) · Genes & Development · doi:10.1101/gad.1742509 · Cited by 366 · see citing works
Karnik, S. K., Chen, H., McLean, G. W., Heit, J. J., Gu, X., Zhang, A. Y., Fontaine, M., Yen, M. H., & Kim, S. K. (2007) · Science · doi:10.1126/science.1146812 · Cited by 353 · see citing works
Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice
Tschen, S.-I., Dhawan, S., Gurlo, T., & Bhushan, A. (2009) · Diabetes · doi:10.2337/db08-1651 · Cited by 331 · see citing works
Adaptive β-Cell Proliferation Is Severely Restricted With Advanced Age
Rankin, M. M., & Kushner, J. A. (2009) · Diabetes · doi:10.2337/db08-1198 · Cited by 327 · see citing works
Huang, C., Snider, F., & Cross, J. C. (2009) · Endocrinology · doi:10.1210/en.2008-1003 · Cited by 275 · see citing works
A MORPHOLOGICAL STUDY OF THE ENDOCRINE PANCREAS IN HUMAN PREGNANCY
Van Assche, F. A., Aerts, L., & Prins, F. D. (1978) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1978.tb15835.x · Cited by 267 · see citing works
Freemark, M. (2002) · Endocrinology · doi:10.1210/en.143.4.1378 · Cited by 258 · see citing works
Garcia-Ocaña, A., Takane, K. K., Syed, M. A., Philbrick, W. M., Vasavada, R. C., & Stewart, A. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1226 · Cited by 247 · see citing works
Perspective: Postnatal Pancreatic β Cell Growth
Bonner‐Weir, S. (2000) · Endocrinology · doi:10.1210/endo.141.6.7567 · Cited by 247 · see citing works
Regulation of Pancreatic β Cell Mass by Neuronal Signals from the Liver
Imai, J., Katagiri, H., Yamada, T., Ishigaki, Y., Suzuki, T., Kudo, H., Uno, K., Hasegawa, Y., Gao, J., Kaneko, K., et al. (2008) · Science · doi:10.1126/science.1163971 · Cited by 236 · see citing works
Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas
Scaglia, L., Smith, F. E., & Bonner-Weir, S. (1995) · Endocrinology · doi:10.1210/en.136.12.5461 · Cited by 225 · see citing works
Uchida, T., Nakamura, T., Hashimoto, N., Matsuda, T., Kotani, K., Sakaue, H., Kido, Y., Hayashi, Y., Nakayama, K. I., White, M. F., et al. (2005) · Nature Medicine · doi:10.1038/nm1187 · Cited by 218 · see citing works
Vasavada, R. C., Garcia-Ocaña, A., Zawalich, W. S., Sorenson, R. L., Dann, P., Syed, M., Ogren, L., Talamantes, F., & Stewart, A. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15399 · Cited by 212 · see citing works
Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas.
Scaglia, L., Smith, F. E., & Bonner‐Weir, S. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588296 · Cited by 211 · see citing works
Bmi-1 regulates the <i>Ink4a/Arf</i> locus to control pancreatic β-cell proliferation
Dhawan, S., Tschen, S.-I., & Bhushan, A. (2009) · Genes & Development · doi:10.1101/gad.1742609 · Cited by 210 · see citing works
Johansson, M., Mattsson, G., Andersson, A., Jansson, L. E., & Carlsson, P. (2006) · Endocrinology · doi:10.1210/en.2005-0997 · Cited by 208 · see citing works
Epigenetic mechanisms in the development of type 2 diabetes
Pinney, S. E., & Simmons, R. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.10.002 · Cited by 205 · see citing works
Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans
Ritzel, R. A., Butler, A. E., Rizza, R. A., Veldhuis, J. D., & Butler, P. C. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1538 · Cited by 197 · see citing works
Zhang, H., Zhang, J., Pope, C. F., Crawford, L. A., Vasavada, R. C., Jagasia, S. M., & GANNON, M. A. (2009) · Diabetes · doi:10.2337/db09-0050 · Cited by 172 · see citing works
Gestational diabetes leads to the development of diabetes in adulthood in the rat
Boloker, J., Gertz, S. J., & Simmons, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1499 · Cited by 170 · see citing works
Greenhalgh, C. J., Bertolino, P., Asa, S. L., Metcalf, D., Corbin, J. E., Adams, T. E., Davey, H. W., Nicola, N. A., Hilton, D. J., & Alexander, W. S. (2002) · Molecular Endocrinology · doi:10.1210/me.16.6.1394 · Cited by 166 · see citing works
Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α
Gupta, R. K., Gao, N., Gorski, R. K., White, P., Hardy, O. T., Rafiq, K., Brestelli, J. E., Chen, G., Stoeckert, C. J., & Kaestner, K. H. (2007) · Genes & Development · doi:10.1101/gad.1535507 · Cited by 161 · see citing works
Self-citationThe transcriptional response of the islet to pregnancy in mice
Rieck, S., White, P., Schug, J., Fox, A. J., Smirnova, O., Gao, N., Gupta, R. K., Wang, Z. V., Scherer, P. E., Keller, M. P., et al. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0144 · Cited by 160 · see citing works
Self-citationEvidence for a circulating islet cell growth factor in insulin-resistant states
Flier, S. N., Kulkarni, R., & Kahn, C. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131192998 · Cited by 156 · see citing works
Parsons, J. A., Bartke, A., & Sorenson, R. L. (1995) · Endocrinology · doi:10.1210/en.136.5.2013 · Cited by 152 · see citing works
Kaung, H. C. (1994) · Developmental Dynamics · doi:10.1002/aja.1002000208 · Cited by 152 · see citing works
Laybutt, D. R., Weir, G. C., Kaneto, H., Lebet, J., Palmiter, R. D., Sharma, A., & Bonner-Weir, S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1793 · Cited by 144 · see citing works
Parsons, J. A., Bartke, A., & Sorenson, R. L. (1995) · Endocrinology · doi:10.1210/endo.136.5.7720649 · Cited by 142 · see citing works
Ekholm, R., Ericson, L. E., & Lundquist, I. (1971) · Diabetologia · doi:10.1007/bf01219468 · Cited by 139 · see citing works
Brelje, T. C., Stout, L. E., Bhagroo, N. V., & Sorenson, R. L. (2004) · Endocrinology · doi:10.1210/en.2004-0201 · Cited by 134 · see citing works
Martín, J., Hunt, S. L., Dubus, P., Sotillo, R., Néhmé-Pélluard, F., Magnuson, M. A., Parlow, A. F., Malumbres, M., Ortega, S., & Barbacid, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206506 · Cited by 122 · see citing works
Fiaschi‐Taesch, N., Bigatel, T. A., Sicari, B. M., Takane, K. K., Salim, F. G., Velázquez-García, S., Harb, G., Selk, K. L., Cózar‐Castellano, I., & Stewart, A. F. (2009) · Diabetes · doi:10.2337/db08-0631 · Cited by 116 · see citing works
Replication Increases β-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis
Ritzel, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1701 · Cited by 115 · see citing works
Ackermann Misfeldt, A., Costa, R. H., & Gannon, M. (2008) · Diabetes · doi:10.2337/db08-0878 · Cited by 114 · see citing works
Human placental growth hormone
Alsat, E., Guibourdenche, J., Luton, D., Frankenne, F., & Evain-Brion, D. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70103-0 · Cited by 113 · see citing works
Amaral, M. E. C., Cunha, D. A., Anhê, G. F., Ueno, M., Carneiro, E. M., Velloso, L. A., Bordin, S., & Boschero, A. C. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05547 · Cited by 110 · see citing works
Regulated β-Cell Regeneration in the Adult Mouse Pancreas
Cano, D. A., Rulifson, I. C., Heiser, P. W., Swigart, L. B., Pelengaris, S., German, M. S., Evan, G. I., Bluestone, J. A., & Hebrok, M. (2007) · Diabetes · doi:10.2337/db07-0913 · Cited by 101 · see citing works
Friedrichsen, B. N., Richter, H. E., Hansen, J. A., Rhodes, C. J., Nielsen, J. H., Billestrup, N., & Møldrup, A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0356 · Cited by 93 · see citing works
Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation
Fujinaka, Y., Takane, K., Yamashita, H., & Vasavada, R. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702607200 · Cited by 92 · see citing works
Zhong, L., Georgia, S., Tschen, S.-I., Nakayama, K., Nakayama, K., & Bhushan, A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32198 · Cited by 92 · see citing works
Klinger, S., Poussin, C., Debril, M.-B., Dolci, W., Halban, P. A., & Thorens, B. (2008) · Diabetes · doi:10.2337/db07-1414 · Cited by 86 · see citing works
PANIC-ATTAC: A Mouse Model for Inducible and Reversible β-Cell Ablation
Wang, Z. V., Mu, J., Schraw, T., Gautron, L., Elmquist, J. K., Zhang, B. B., Brownlee, M., & Scherer, P. E. (2008) · Diabetes · doi:10.2337/db07-1631 · Cited by 65 · see citing works
Autocrine Regulation of Single Pancreatic β-Cell Survival
Navarro‐Tableros, V., Sánchez-Soto, M. C., García, S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2018 · Cited by 65 · see citing works
(2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-41303 · Cited by 61 · see citing works
Perspective: Postnatal Pancreatic Cell Growth
Bonner‐Weir, S. (2000) · Endocrinology · doi:10.1210/en.141.6.1926 · Cited by 61 · see citing works
Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets
Fiaschi-Taesch, N. M., Berman, D. M., Sicari, B. M., Takane, K. K., Garcia-Ocaña, A., Ricordi, C., Kenyon, N. S., & Stewart, A. F. (2008) · Diabetes · doi:10.2337/db08-1085 · Cited by 59 · see citing works
The endocrine pancreas in virgin and pregnant offspring of diabetic pregnant rats
Aerts, L., Vercruysse, L., & Van Assche, F. A. (1997) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(97)00080-6 · Cited by 55 · see citing works
Matveyenko, A. V., Veldhuis, J. D., & Butler, P. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90451.2008 · Cited by 54 · see citing works
Cózar‐Castellano, I., Haught, M., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/db06-0627 · Cited by 47 · see citing works
In vitro and in vivo improvement of islet survival following treatment with nerve growth factor
Miao, G., Mace, J., Kirby, M., Hopper, A., Peverini, R., Chinnock, R., Shapiro, J., & Hathout, E. (2006) · Transplantation · doi:10.1097/01.tp.0000200320.16723.b3 · Cited by 44 · see citing works
Pechhold, S. B., Stouffer, M. A., Walker, G., Martel, R. R., Seligmann, B. E., Hang, Y., Stein, R. W., Harlan, D. M., & Pechhold, K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1579 · Cited by 42 · see citing works
Postnatal Expansion of the Pancreatic β-Cell Mass Is Dependent on Survivin
Jiang, Y., Nishimura, W., Devor-Henneman, D., Kusewitt, D., Wang, H., Holloway, M. P., Dohi, T., Sabo, E., Robinson, M. L., Altieri, D. C., et al. (2008) · Diabetes · doi:10.2337/db08-0170 · Cited by 38 · see citing works
Richmond, J. E., Codignola, A., Cooke, I. M., & Sher, E. (1996) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050132 · Cited by 36 · see citing works
Dohi, T., Salz, W., Costa, M., Ariyan, C., Basadonna, G. P., & Altieri, D. C. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400640 · Cited by 32 · see citing works
Endo, T. (2003) · Journal of Biochemistry · doi:10.1093/jb/mvg004 · Cited by 31 · see citing works
Radziszewska, A., Schroer, S. A., Choi, D., Tajmir, P., Radulovich, N., Ho, J. C., Wang, L., Liadis, N., Hakem, R., Tsao, M.-S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806960200 · Cited by 22 · see citing works
Aerts, L., & Van Assche, F. A. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00063-1 · Cited by 17 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Kloppel, 1985, Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited, Surv. Synth. Pathol. Res., 4, 110
- Butler, 2003, Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid, Diabetes, 52, 2304, 10.2337/diabetes.52.9.2304 · DOI · Paper page
Cited by
Sorted by citations
The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation
Napso, T., Yong, H. E. J., Lopez-Tello, J., & Sferruzzi-Perri, A. N. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01091 · Cited by 470 · see citing works
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy
Butler, A. E., Cao-Minh, L., Galasso, R., Rizza, R. A., Corradin, A., Cobelli, C., & Butler, P. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1809-6 · Cited by 435 · see citing works
PDGF signalling controls age-dependent proliferation in pancreatic β-cells
Chen, H., Gu, X., Liu, Y., Wang, J., Wirt, S. E., Bottino, R., Schorle, H., Sage, J., & Kim, S. K. (2011) · Nature · doi:10.1038/nature10502 · Cited by 278 · see citing works
Sandovici, I., Hoelle, K., Angiolini, E., & Constância, M. (2012) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2012.03.017 · Cited by 224 · see citing works
β-cell adaptation in pregnancy
Baeyens, L., Hindi, S., Sorenson, R. L., & German, M. S. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12716 · Cited by 210 · see citing works
Avrahami, D., Li, C., Zhang, J., Schug, J., Avrahami, R., Rao, S., Stadler, M. B., Burger, L., Schübeler, D., Glaser, B., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.025 · Cited by 207 · see citing works
Self-citationLorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202 · see citing works
Human β-Cell Proliferation and Intracellular Signaling: Part 3
Stewart, A. F., Hussain, M. A., García-Ocaña, A., Vasavada, R. C., Bhushan, A., Bernal-Mizrachi, E., & Kulkarni, R. N. (2015) · Diabetes · doi:10.2337/db14-1843 · Cited by 142 · see citing works
Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells
Banerjee, R. R., Cyphert, H. A., Walker, E. M., Chakravarthy, H., Peiris, H., Gu, X., Liu, Y., Conrad, E., Goodrich, L., Stein, R. W., et al. (2016) · Diabetes · doi:10.2337/db15-1527 · Cited by 131 · see citing works
Moyce, B. L., & Dolinsky, V. W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113467 · Cited by 128 · see citing works
Advancements and challenges in generating accurate animal models of gestational diabetes mellitus
Pasek, R. C., & Gannon, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00425.2013 · Cited by 90 · see citing works
Retnakaran, R., Ye, C., Kramer, C. K., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B. (2016) · Diabetes Care · doi:10.2337/dc16-0043 · Cited by 64 · see citing works
Ando, H., Gotoh, K., Fujiwara, K., Anai, M., Chiba, S., Masaki, T., Kakuma, T., & Shibata, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-05371-4 · Cited by 14 · see citing works
- Authors
- Rieck, S., & Kaestner, K. H.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kaestner, Klaus H.
- ORCID
- Kaestner, Klaus H.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 21
- Issue
- 3
- Pages
- 151-158
- ISSN
- 1043-2760 (ISSN-L)
- PMC
- PMC3627215
- OpenAlex
- W2011220884
- Semantic Scholar
- d361f3febb63c8c5345337b00d99d4870139bf79
- Cited by
- 358
- References
- 85
- Citations by year
- 2026: 16 · 2025: 13 · 2024: 20 · 2023: 25 · 2022: 25 · 2021: 22 · 2020: 24 · 2019: 20 · 2018: 21 · 2017: 17 · 2016: 29 · 2015: 28 · 2014: 32 · 2013: 22 · 2012: 16
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK055243, R01DK055342)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell mass expansion, pregnancy, beta-cell proliferation, beta-cell apoptosis, insulin resistance, islet transplantation, insulin deficiency, diabetes mellitus
- MeSH terms
- Animals, Diabetes Mellitus, Female, Humans, Insulin Resistance, Models, Biological, Pregnancy, Apoptosis, Cell Size, Cell Proliferation, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review